MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,056,376,000 | +203.7% | 39,184 | +92.5% | 0.00% | +200.0% |
| Q2 2020 | $677,078,000 | -58.9% | 20,351 | -66.4% | 0.00% | -66.7% |
| Q1 2020 | $1,646,661,000 | +117.8% | 60,539 | +58.0% | 0.00% | +200.0% |
| Q4 2019 | $755,955,000 | +88.6% | 38,315 | +23.9% | 0.00% | 0.0% |
| Q3 2019 | $400,723,000 | +142.8% | 30,920 | +133.2% | 0.00% | – |
| Q2 2019 | $165,050,000 | -48.4% | 13,257 | -39.8% | 0.00% | -100.0% |
| Q1 2019 | $319,892,000 | +1575.9% | 22,016 | +1173.3% | 0.00% | – |
| Q4 2018 | $19,088,000 | -83.2% | 1,729 | -60.0% | 0.00% | – |
| Q3 2018 | $113,669,000 | +29.9% | 4,322 | +1.0% | 0.00% | – |
| Q2 2018 | $87,526,000 | -80.3% | 4,280 | -82.5% | 0.00% | -100.0% |
| Q1 2018 | $443,423,000 | +0.3% | 24,431 | -22.9% | 0.00% | 0.0% |
| Q4 2017 | $442,201,000 | -39.5% | 31,699 | -19.7% | 0.00% | -50.0% |
| Q3 2017 | $730,602,000 | +99.8% | 39,492 | +82.5% | 0.00% | +100.0% |
| Q2 2017 | $365,716,000 | +104.5% | 21,640 | +61.6% | 0.00% | – |
| Q1 2017 | $178,797,000 | +0.5% | 13,393 | +13.3% | 0.00% | -100.0% |
| Q4 2016 | $177,936,000 | +56.1% | 11,823 | +21.2% | 0.00% | – |
| Q3 2016 | $114,001,000 | -46.7% | 9,752 | -50.8% | 0.00% | -100.0% |
| Q2 2016 | $214,013,000 | +151.8% | 19,816 | +115.4% | 0.00% | – |
| Q1 2016 | $84,999,000 | -54.8% | 9,199 | -27.5% | 0.00% | – |
| Q4 2015 | $188,230,000 | -34.6% | 12,684 | -27.7% | 0.00% | -100.0% |
| Q3 2015 | $287,864,000 | +148.3% | 17,542 | +245.2% | 0.00% | – |
| Q2 2015 | $115,920,000 | +570.8% | 5,082 | +347.0% | 0.00% | – |
| Q1 2015 | $17,282,000 | -46.6% | 1,137 | -60.2% | 0.00% | – |
| Q3 2014 | $32,387,000 | +199.3% | 2,856 | +366.7% | 0.00% | – |
| Q4 2013 | $10,820,000 | -94.1% | 612 | -95.2% | 0.00% | – |
| Q3 2013 | $184,365,000 | -24.2% | 12,812 | -20.6% | 0.00% | – |
| Q2 2013 | $243,114,000 | – | 16,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
| Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
| Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
| Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
| Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
| Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
| Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
| Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
| Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
| Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |